Compass Pathways Plc - ADR Share
€5.70
1.89%
today
L&S,
Jun 28, 03:34 pm CET
Compass Pathways Plc - ADR Share price
$5.99
-1.49
19.92%
1M
-3.06
33.81%
6M
-2.76
31.54%
YTD
-1.87
23.79%
1Y
-30.71
83.68%
3Y
-11.01
64.76%
5Y
-11.01
64.76%
10Y
Nasdaq,
Closing price Thu, Jun 27 2024
Powered by
Key figures
| Market capitalization | $409.37m |
| Enterprise Value | $178.90m |
| PER (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 1.58 |
| Turnover (TTM) Turnover | $0.00 |
| EBIT (operating result TTM) EBIT | $-143.92m |
| Free cash flow (TTM) Free cash flow | $-91.11m |
| Cash position | $263.28m |
Show more
Is Compass Pathways Plc - ADR a top scorer stock according to the dividend, high growth investing or Leverman strategy?
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
Compass Pathways Plc - ADR Share analysis
Unlock scores for free
Analyst opinions
10 Analysts have issued a Compass Pathways Plc - ADR forecast:
Analyst opinions
10 Analysts have issued a Compass Pathways Plc - ADR forecast:
Buy
100%
Financial data from Compass Pathways Plc - ADR
| Mar '24 |
+/-
%
|
||
| Turnover | - - |
-
|
|
| Gross income | - - |
-
|
|
| EBITDA | -144 -144 |
24%
24%
|
EBIT (operating result) EBIT | -144 -144 |
23%
23%
|
| Net profit | -130 -130 |
37%
37%
|
|
Figures in millions USD.
Don't miss a thing! We will send you all news about the Compass Pathways Plc - ADR share directly to your mailbox free of charge.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Compass Pathways Plc - ADR Share News
Neutral
GlobeNewsWire
●
2 days ago
LONDON, June 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today announced the appointment of Lori Englebert as Chief Commercial Officer, effective July 8, 2024. She will be based in the company's New York City office.
Neutral
GlobeNewsWire
●
4 days ago
LONDON, June 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference at 7:00 am ET on June 27, 2024. The company will also participate in a panel...
Neutral
The Motley Fool
●
16 days ago
Compass Pathways stock took a hit in early June. Lykos Therapeutics just got some extremely bearish news from regulators.
Company profile
| Head office | United Kingdom |
| CEO | Kabir Nath |
| Employees | 186 |
| Founded | 2016 |
| Website | www.compasspathways.com |
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
